If this laboratory pleases the American president so much, it is because he claims to be “a few months away” from a vaccine project. Germany has declared it inadmissible.
After qualifying the coronavirus “European virus”, Donald Trump would not now be against offering the services of German researchers who are currently working on the development of a vaccine. In any case, the German daily claims Die Welt (article in German), Sunday March 15.
According to the newspaper, the American president wants to take over the laboratory CureVac, located in Tübingen (Land of Baden-Württemberg), in the south-west of the country, by offering him a very large sum of money. Information confirmed by the German government in the process. “I can only say that I have heard from government officials today several times that this is correct”said Interior Minister Horst Seehofer at a press conference.
The latter also announced that the subject would be raised on Monday by the “crisis committee” of the government responsible for piloting the fight against the coronavirus epidemic, which to date has affected nearly 5,000 people in Germany and has left 12 dead.
If Donald Trump likes this laboratory so much, it is because he is one of those in the world working on a vaccine, benefiting from subsidies from the German government. He claims to be “a few months” to be able to present a project for validation.
According to the German newspaper, the American president is therefore trying to attract millions of dollars from German scientists working on this potential vaccine or to obtain exclusivity for his country by investing in the company. This vaccine would then “only for the United States”, a source close to the German government told the newspaper.
The CEO of the laboratory was also personally invited by the American president on March 3 to the White House to discuss “strategies and opportunities for rapid development of a coronavirus vaccine”, according to a press release made public by the company itself. Curiously, the company CureVac announced a week later, on March 11, the surprise departure of this CEO, without giving any reason. In the meantime, resistance was clearly organized on the German side, and in particular within the company concerned, in the face of American inclinations.
–
